O'Shaughnessy Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,117
Closed -$59.6K 2718
2025
Q3
$59.6K Sell
14,117
-4,560
-24% -$21.2K ﹤0.01% 2164
2025
Q2
$68.4K Sell
18,677
-25,637
-58% -$95.6K ﹤0.01% 2005
2025
Q1
$191K Sell
44,314
-3,092
-7% -$12.5K ﹤0.01% 1787
2024
Q4
$152K Buy
47,406
+31,290
+194% +$105K ﹤0.01% 1802
2024
Q3
$49.8K Buy
16,116
+1,601
+11% +$4.49K ﹤0.01% 1870
2024
Q2
$40.6K Buy
+14,515
New +$39K ﹤0.01% 1736
2021
Q4
Sell
-1,412
Closed -$20K 2092
2021
Q3
$20K Hold
1,412
﹤0.01% 1946
2021
Q2
$23K Buy
+1,412
New +$26.3K ﹤0.01% 1801

Other funds holding ORGO

O'Shaughnessy Asset Management's ORGO Position: Q4 2025 in Review

O'Shaughnessy Asset Management sold out of Organogenesis Holdings (ORGO) in Q4 2025, closing a stake of 14,117 shares — an estimated $59.6K sold.

O'Shaughnessy Asset Management first reported a position in ORGO in Q2 2021 and held it in 8 quarters. The position peaked at $191K in Q1 2025. 147 funds tracked by Wall St. Rank hold ORGO as of Q4 2025.

  • O'Shaughnessy Asset Management reported no remaining Organogenesis Holdings position as of Q4 2025 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 14,117 Organogenesis Holdings shares in Q4 2025, an estimated $59.6K.
  • O'Shaughnessy Asset Management first reported a position in Organogenesis Holdings in Q2 2021 and held it in 8 quarters.
  • O'Shaughnessy Asset Management's Organogenesis Holdings position peaked at $191K in Q1 2025.
  • 147 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2025.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.